Kis dózisú kemoterápiával kombinált sugárterápiával szerzett eredményeink lokálisan elôrehaladott stádiumú fej-nyaki rákban.

Translated title of the contribution: Radiotherapy in combination with low-dose chemotherapy in locally advanced head and neck cancer

Beatrix Nagy, József Molnár, László Rovó, Róbert Paczona, László Thurzó

Research output: Contribution to journalArticle

Abstract

A previous preclinical study revealed that the maximal additive effect between chemotherapy (CT) and irradiation (RT) occurred at a low level of CT. Therapy was therefore designed with an oral drug daily given in combination with RT in order to determine the efficacy and toxicity. Locoregionally advanced head and neck tumor patients were treated with simultaneous RT and CT. RT was administered 5 times per week at 2 Gy per fraction in a total dose of 70 Gy. Throughout the treatment 30 mg/kg Tegafur was given daily orally. In the period between 2000 and 2002, 50 patients were enrolled. Complete remission was attained in 60%, with an overall response rate of 94%. Acute mucositis of grade 2 or 3 was observed in 56% (28 patients), and gastrointestinal and hematologic toxicity of grade 2 or 3 occurred in 8% (4 patients). Because of side-effects, the duration of treatment was at most 2 weeks longer. Toxicity was eliminated quickly by careful supportive therapy. In conclusion, it is considered that oral low-dose CT in combination with RT is an efficient and simple mode of treatment for locally advanced head and neck tumor patients with a poor prognosis.

Original languageHungarian
Pages (from-to)145-149
Number of pages5
JournalMagyar Onkologia
Volume48
Issue number2
Publication statusPublished - 2004

Fingerprint

Head and Neck Neoplasms
Radiotherapy
Drug Therapy
Neck
Head
Tegafur
Therapeutics
Mucositis
Combination Drug Therapy
Neoplasms
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research

Cite this

Kis dózisú kemoterápiával kombinált sugárterápiával szerzett eredményeink lokálisan elôrehaladott stádiumú fej-nyaki rákban. / Nagy, Beatrix; Molnár, József; Rovó, László; Paczona, Róbert; Thurzó, László.

In: Magyar Onkologia, Vol. 48, No. 2, 2004, p. 145-149.

Research output: Contribution to journalArticle

@article{bc6de6ca523842829a846cfe62efd320,
title = "Kis d{\'o}zis{\'u} kemoter{\'a}pi{\'a}val kombin{\'a}lt sug{\'a}rter{\'a}pi{\'a}val szerzett eredm{\'e}nyeink lok{\'a}lisan el{\^o}rehaladott st{\'a}dium{\'u} fej-nyaki r{\'a}kban.",
abstract = "A previous preclinical study revealed that the maximal additive effect between chemotherapy (CT) and irradiation (RT) occurred at a low level of CT. Therapy was therefore designed with an oral drug daily given in combination with RT in order to determine the efficacy and toxicity. Locoregionally advanced head and neck tumor patients were treated with simultaneous RT and CT. RT was administered 5 times per week at 2 Gy per fraction in a total dose of 70 Gy. Throughout the treatment 30 mg/kg Tegafur was given daily orally. In the period between 2000 and 2002, 50 patients were enrolled. Complete remission was attained in 60{\%}, with an overall response rate of 94{\%}. Acute mucositis of grade 2 or 3 was observed in 56{\%} (28 patients), and gastrointestinal and hematologic toxicity of grade 2 or 3 occurred in 8{\%} (4 patients). Because of side-effects, the duration of treatment was at most 2 weeks longer. Toxicity was eliminated quickly by careful supportive therapy. In conclusion, it is considered that oral low-dose CT in combination with RT is an efficient and simple mode of treatment for locally advanced head and neck tumor patients with a poor prognosis.",
author = "Beatrix Nagy and J{\'o}zsef Moln{\'a}r and L{\'a}szl{\'o} Rov{\'o} and R{\'o}bert Paczona and L{\'a}szl{\'o} Thurz{\'o}",
year = "2004",
language = "Hungarian",
volume = "48",
pages = "145--149",
journal = "Magyar Onkologia",
issn = "0025-0244",
publisher = "Akademiai Kiado",
number = "2",

}

TY - JOUR

T1 - Kis dózisú kemoterápiával kombinált sugárterápiával szerzett eredményeink lokálisan elôrehaladott stádiumú fej-nyaki rákban.

AU - Nagy, Beatrix

AU - Molnár, József

AU - Rovó, László

AU - Paczona, Róbert

AU - Thurzó, László

PY - 2004

Y1 - 2004

N2 - A previous preclinical study revealed that the maximal additive effect between chemotherapy (CT) and irradiation (RT) occurred at a low level of CT. Therapy was therefore designed with an oral drug daily given in combination with RT in order to determine the efficacy and toxicity. Locoregionally advanced head and neck tumor patients were treated with simultaneous RT and CT. RT was administered 5 times per week at 2 Gy per fraction in a total dose of 70 Gy. Throughout the treatment 30 mg/kg Tegafur was given daily orally. In the period between 2000 and 2002, 50 patients were enrolled. Complete remission was attained in 60%, with an overall response rate of 94%. Acute mucositis of grade 2 or 3 was observed in 56% (28 patients), and gastrointestinal and hematologic toxicity of grade 2 or 3 occurred in 8% (4 patients). Because of side-effects, the duration of treatment was at most 2 weeks longer. Toxicity was eliminated quickly by careful supportive therapy. In conclusion, it is considered that oral low-dose CT in combination with RT is an efficient and simple mode of treatment for locally advanced head and neck tumor patients with a poor prognosis.

AB - A previous preclinical study revealed that the maximal additive effect between chemotherapy (CT) and irradiation (RT) occurred at a low level of CT. Therapy was therefore designed with an oral drug daily given in combination with RT in order to determine the efficacy and toxicity. Locoregionally advanced head and neck tumor patients were treated with simultaneous RT and CT. RT was administered 5 times per week at 2 Gy per fraction in a total dose of 70 Gy. Throughout the treatment 30 mg/kg Tegafur was given daily orally. In the period between 2000 and 2002, 50 patients were enrolled. Complete remission was attained in 60%, with an overall response rate of 94%. Acute mucositis of grade 2 or 3 was observed in 56% (28 patients), and gastrointestinal and hematologic toxicity of grade 2 or 3 occurred in 8% (4 patients). Because of side-effects, the duration of treatment was at most 2 weeks longer. Toxicity was eliminated quickly by careful supportive therapy. In conclusion, it is considered that oral low-dose CT in combination with RT is an efficient and simple mode of treatment for locally advanced head and neck tumor patients with a poor prognosis.

UR - http://www.scopus.com/inward/record.url?scp=7944230334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7944230334&partnerID=8YFLogxK

M3 - Article

C2 - 15351810

VL - 48

SP - 145

EP - 149

JO - Magyar Onkologia

JF - Magyar Onkologia

SN - 0025-0244

IS - 2

ER -